Q-omics provides the consensus-scored CTDSPL2P2 profile across patient tissues and cancer cell-line models. CTDSPL2P2 expression is associated with patient survival in 11 of 34 cancer types, with the highest sampling consensus in BRCA. Additionally, CTDSPL2P2 RNA expression shows 5,718 significant gene co-expression associations, with the highest sampling consensus in COAD. Together, these results highlight BRCA, and COAD as cancer lineages where CTDSPL2P2 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.